Red wine micronutrients as protective agents in Alzheimer-like induced insult

Life Sciences

Volumn 72, Issue 21, 2003, Pages 2369-2379

  Russo, A ^a   Palumbo, M ^a   Aliano, C ^a   Lempereur, L ^a   Scoto, G ^a   Renis, M ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

25 35 amyloid peptide; Alzheimer's disease; Grape skin; Human umbilical vein endothelial cells (HUVECs); Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; DNA FRAGMENT; LACTATE DEHYDROGENASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; RES VIN; TRACE ELEMENT;

ALZHEIMER DISEASE; ARTICLE; CELL MEMBRANE; COMET ASSAY; CONTROLLED STUDY; CYTOPLASM; DNA DAMAGE; ENDOTHELIUM CELL; ENZYME RELEASE; FEMALE; GRAPEFRUIT JUICE; HUMAN; HUMAN CELL; MITOCHONDRION; OXIDATIVE STRESS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WINE;

VITIS SP.;

EID: 0037432493     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00123-1     Document Type: Article

References (43)

1. Acquaviva R., Russo A., Campisi A., Sorrenti V., Di Giacomo C., Barcellona M.L., Avitabile M., Vanella A. Antioxidant activity and protective effect on DNA cleavage of resveratrol. Journal Food Sciences. 67(1):2002;137-141.
2. Beal M.F. Mitochondria, free radicals, and neurodegeneration. Current Opinion in Neurobiology. 6(5):1996;661-666.
3. Bertelli A.A., Giovannini L.L., Bernini W., Migliori M., Fregoni M., Bavaresco L., Bertelli A. Antiplatelet activity of cis-resveratrol. Drugs Experimental Clinical Research. 22(2):1996;61-63.
4. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analitical Biochemistry. 72(7):1976;248-254.
5. 3. Free Radical Biological and Medicine. 26(11-12):1999;1531-1537.
6. Chanvitayapongs S., Draczynska-Lusiak B., Sun A.Y. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport. 8(6):1997;1499-1502.
7. Cuajungco M.P., Goldstein L.E., Nunomura A., Smith M.A., Lim J.T., Atwood C.S., Huang X., Farrag Y.W., Perry G., Bush A.I. Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Abeta by zinc. Journal Biological Chemistry. 275(26):2000;19439-19442.
8. Frankel E.N., Waterhouse A.L., Kinsella J.E. Inhibition of Human LDL oxidation by resveratrol. Lancet. 341(8852):1993;1103-1104.
9. Gnjec A., Fonte J.A., Atwood C., Martins R.N. Transition metal chelator therapy a potential treatment for Alzheimer's disease? Frontiers in Biosciencee. 7(d):2002;1016-1023.
10. Haass C., De Strooper B. The presenilins in Alzheimer's disease-proteolysis holds the key. Science. 286(5441):1999;916-919.
11. Huang X., Cuajungco M.P., Atwood C.S., Hartshom M.A., Tyndall J.D., Hanson G.R., Stokes K.C., Leopold M., Multhaup G., Goldstein L.E., Scarpa R.C., Saunders A.J., Lim J., Moir R.D., Glabe C., Bowden E.F., Masters C.L., Fairlie D.P., Tanzi R.E., Bush A.I. Cu(II) potentiation of Alzheimer Aβ neurotoxicity. Correlation with cell free hydrogen peroxide production and metal reduction. Journal Biological Chemistry. 274(52):1999;37111-37116.
12. Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.P., Ruberg M., Foucheux B.A. Nuclear traslocation of NF-kB is increased in dopaminergic neurons of patients with Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. 94(14):1997;7531-7536.
13. Inanami O., Watanabe Y., Syuto B., Nakano M., Tsuji M., Kuwabara M. Oral administration of (-) catechin protects against ischemia-reperfusion induced neuronal death in the gerbil. Free Radical Research. 29(4):1998;359-365.
14. Jackson G.R., Werrbach-Perez K., Pan Z., Sampth D., Perez-Polo J.R. Neurotrophin regulation of energy homeostasis in the central nervous system. Development Neuroscience. 16(5-6):1994;285-290.
15. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilicals veins. Identification by morphologic and immunologic criteria. Journal Clinical Investigation. 52(11):1973;2745-2756.
16. Jagust W.J., Seab J.B., Huesman R.H., Volk P.E., Mathis C.A., Reed B.R., Coxson P.G., Budinger T.F. Diminished glucose transport in Alzheimer's disease: dynamic PET studies. Journal of Cerebral Blood Flow and Metabolism. 11(2):1991;323-330.
17. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghom A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275(5297):1997;218-220.
18. Kampa M., Hatzoglou A., Notas G., Damianaki A., Bakogeorgou E., Gemetzi C., Kouroumalis E., Martin P.M., Castanas E. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutrition Cancer. 37(2):2000;223-233.
19. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Archives of Neurology. 42(11):1985;1097-1105.
20. King T.E. Preparation of succinate cytochrome-c reductase and the cytochrome b-cl particle and reconstitution of succinate-c reductase. Methods Enzymology. 10:1967;216-225.
21. Maccioni R.B., Munoz J.P., Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Archives of Medical Research. 32(5):2001;367-381.
22. Maesaka J.K., Palaia T., Chowdhury S.A., Shimamura T., Fishbane S., Reichman W., Coyne A., O'Rear J.J., El-Sabban M.E. Partial characterization of apoptotic factor in Alzheimer plasma. American Journal Physiology. 276(4Pt. 2):1999;521-527.
23. Maniero E., Lombardi V.R.M., Lagares R., Cacabelos R. An experimental model to study the cytotoxic effects induced by β-amyloidal, istamine, LPS and serum from Alzheimer patients on cultured rat endothelial cells. Methods and Findings in Experimental and Clinical Pharmacology. 19(1):1997;5-12.
24. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biological Medicine. 23(1):1997;134-147.
25. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer diseases. Brain Research Review. 21(2):1995;195-218.
26. Murphy T.H., Baraban J.M. Glutamate toxicity in immature cortical neurons precedes development of glutamate receptor currents. Development Brain Research. 57(1):1990;146-150.
27. Noda Y., Anzai K., Mori A., Kohono M., Shimnei M., Packer L. Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectromoter system. Biochemistry and Molecular Biology International. 42(1):1997;35-44.
28. Obisesan T.O., Hirsh R., Kosoko O., Carlson L., Parrott M. Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1. Journal American Gerontology Society. 46:1997;1-7.
29. Orgogozo J.M., Dartigues J.F., Lafont S., Letenneur L., Commenges D., Salomon R., Renaud S., Breteler M.B. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Revue Neurologique. 153(3):1997;185-192.
30. Oteiza P.I.A. A mechanism for the stimulatory effect of aluminium on iron-induced lipid peroxidation. Archieves Biochemical Biophysic. 308(2):1994;374-379.
31. Pace-Asciak C.R., Hahn S., Diamandis E.P., Soleas G., Goldberg D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clinica Chimica Acta. 235(2):1995;207-219.
32. Ragan C.I., Wilson M.T., Darley-Usmar V.M., Lowe P.N. Subfraction of mitochondria and of the proteins of oxidative phosphorilation. Darley-Usmar V.M., Rickwood D., Wilson M.T. Mitochondria, a pratical approach. 1987;79-112 IRL Press, London.
33. Renaud S.K., De Lorgnel M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet. 339(8808):1992;1523-1526.
34. Rice-Evans C., Halliwell B., Lunt G.G. Free radicals and oxidative stress: Environment, Drugs and Food additives. 2nd ed. 1995;Portland Press, London.
35. Rodriguez-Santiago B., Casademont J., Nunes V. Is mitochondrial DNA depletion involved in Alzheimer's disease? European Journal of Human Genetics. 9(4):2001;279-285.
36. Shutenko Z., Henry Y., Pinard E., Seylaz J., Potier P., Berthet F., Girard P., Sercombe R. Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion. Biochemical Pharmacology. 57(2):1999;199-208.
37. Singh N.P., Tice R.R., Stephens R.E., Scheneider E.L. A microgel electrophoresis technique for the direct quantitation of DNA damage and repair in individual fibroblasts cultured on microscope slides. Mutation Research. 252(3):1991;289-296.
38. Smith M.A., Rottkamp C.A., Numomura A., Raina A.K., Perry G. Oxidative stress in Alzheimer's disease. Biochimica Biophysica Acta. 1502(1):2000;139-144.
39. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: a molecule whose time has come? And gone? Clinical Biochemistry. 30(2):1997;91-113.
40. Thomas T., Thomas G., McLendon C., Sutton T., Mullan M. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 380(6570):1996;168-171.
41. Virgili M., Contestabile A. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neuroscience Letters. 281(2-3):2000;123-126.
42. Wharton D.C., Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. Methods Enzymology. 10:1967;245-250.
43. Yatin S.M., Aksenov M., Butterfield D.A. The antioxidant vitamin E modulates amyloid β peptide-induced creatine chinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer disease. Neurochemical Research. 24(3):1999;427-435.